Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Dupuis, CA
Alexandre Dupuis, Dollard Des Ormeaux CA
| Patent application number | Description | Published |
|---|---|---|
| 20090097809 | Ferroelectric all-polymer hollow bragg fibers for terahertz guidance - A method for fabricating a terahertz waveguide comprises forming a multilayer reflector formed of alternating layers of first and second polymer materials with distinct refractive indices, and defining with the multilayer reflector a hollow core through which terahertz radiation propagates. The corresponding terahertz waveguide comprises the multilayer reflector formed of the alternating layers of the first and second polymer materials with distinct refractive indices, and a hollow core defined by the multilayer reflector and through which terahertz radiation propagates. | 04-16-2009 |
A. Richard Dupuis, Pickering CA
| Patent application number | Description | Published |
|---|---|---|
| 20100262357 | ANTI IDLING CONTROL SYSTEM AND METHOD OF CONTROLLED ENGINE SHUTDOWN - A system is provided for automatically shutting off a running internal combustion engine after a predetermined length of idle time has occurred, for installation into a vehicle having electronic diagnostic and control computers incorporated to the vehicle. A first switching apparatus is provided, having open and closed modes for disabling and enabling the ignition system respectively. A second switching apparatus is provided, having open and closed modes for disabling and enabling the ignition system. A data collection device receives data from the connected vehicle diagnostic port including: battery level, engine RPM, vehicle speed, door ajar status, ambient temperature, handbrake status and brake pedal position. A computer is programmed to determine if the data from the diagnostic port set up the prerequisites to safe shutdown engine running operation, and to signal the first and second switching apparatuses to shut down the vehicle engine. | 10-14-2010 |
Catherine Dupuis, Montreal CA
| Patent application number | Description | Published |
|---|---|---|
| 20090076168 | AMINE-BASED AND IMINE-BASED POLYMERS, USES AND PREPARATION THEREOF - The present invention relates to a modified polysaccharide prepared from the reaction between a polysaccharide comprising a plurality of monosaccharide subunits having at least one primary amino group, and an hydrophobic aldehyde. The aldehyde and the amino group form together an imine or amine group. The process for preparation and use in cosmetic, pharmaceutical and food industry of the modified polysaccharide is also disclosed. | 03-19-2009 |
Claude Dupuis, Jonquiere CA
| Patent application number | Description | Published |
|---|---|---|
| 20080307927 | In-Line Salt Refining of Molten Aluminium Alloys - The present invention describes an apparatus and a process for in-line substantially continuous degassing of aluminium and/or aluminium alloys, in absence of chlorine and through the injection of at least one metal halide salt that includes a halogen and water and an inert gas, in a transfer trough before casting. | 12-18-2008 |
Craig Dupuis, Windsor CA
| Patent application number | Description | Published |
|---|---|---|
| 20090188456 | CAMSHAFT ADJUSTING DEVICE - The camshaft adjusting device has an inner spring retainer which mates with a rotor and an outer spring retainer which is fixed on a spring cover plate. | 07-30-2009 |
Danny Dupuis, Sainte-Julie CA
| Patent application number | Description | Published |
|---|---|---|
| 20090130898 | Electrical Connector - Described are electrical connectors for hi-power applications where multiple electrical wires are to be maintained apart and electrically insulated from one another. The connectors are to be used to mount the plurality of wires to a receptacle of a casing so as to establish a connection with electric circuit(s) provided inside the casing. Portions of the connector interact with the casing to provide a seal therebetween to prevent the water and dirt infiltration inside the casing. | 05-21-2009 |
Darcy Dupuis, Devon CA
| Patent application number | Description | Published |
|---|---|---|
| 20120073675 | STORAGE TANK SYSTEM HAVING EASE OF PLACEMENT AND INTERCONNECTIVITY - A storage tank system stores liquid containing debris. The sidewalls of the tank have a curved lower portion for receiving debris settling out of the liquid and for directing at least some of the debris to a base of the tank. The tank is also provided with a plurality of nozzles spaced longitudinally along the curved lower portion the sidewalls for directing flush liquid downwardly against the curved lower portion for flushing any residual debris remaining thereon towards the bottom of the tank. The tank has a skid equipped with rollers for improved manoeuvrability in a berm environment and manifolds for improved interconnectability with other tanks. | 03-29-2012 |
| 20120076588 | MODULAR BERM SYSTEM AND METHOD OF ASSEMBLY - A modular berm system and method for installing the berm system about a containment area are provided. The berm system is formed by interconnecting a plurality of panels in an end-to-end arrangement. Corner pieces which enhance the modularity, stability and rigidity of the berm system are also provided. A continuous liquid barrier liner overlies the containment area and the supporting perimeter of panels. The liner blocks any discontinuities between panels. Discontinuities can be overlapped with flaps for protection of the liner. | 03-29-2012 |
Gilles Dupuis, Sherbrooke CA
| Patent application number | Description | Published |
|---|---|---|
| 20080293671 | Combination of Polychitosamine and Fibrate for the Prevention and Treatment of Hyperlipidemia - The present invention relates to pharmaceutical compositions comprising a fibrate (e.g. ciprofibrate, gemfibrozil, benzafibrate, and fenofibrate) and a polychitosamine (e.g. chitosan) having molecular weights of less than 650 Kda and degrees of deacetylation of from 70% to 100%. Uses of said compositions for the treatment of hyperlipidemia and associated conditions (e.g. hypercholesterolemia, atherosclerosis, coronary heart disease and cardiovascular disease) or as functional foods are also disclosed. | 11-27-2008 |
| 20090054373 | CHITIN DERIVATIVES FOR HYPERLIPIDEMIA - The preferred embodiments relate to chitin derivatives for prevention or treatment of hyperlipidemia, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The preferred embodiments are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal. | 02-26-2009 |
| 20090149639 | A Simplified Method To Retrieve Chitosan From Acidic Solutions Thereof - Compositions of salted out chitosan polymer containing mixture of certain salting out salts as well as methods for making and using same are disclosed. Chitosan polymer preparations produced by such methods are substantially free of chitosanase, undesirable salts and excess acid and retain their physiological as well as biological and physico-chemical properties. The chitosan preparations of the present invention are valuable for the dispensing of biologically active chitosan in forms of drugs or food supplement. Most of these preparations easily dissolve in an aqueous acidic milieu such as the one of the stomach. | 06-11-2009 |
| 20110028429 | COMBINATION OF POLYCHITOSAMINE AND HMG-COA REDUCTASE INHIBITOR FOR HYPERLIPIDEMIA - Combinations of therapeutic compounds for prophylaxis or treatment of hyperlipidemia and hyperlipidemia related disorders, such as hypercholesterolemia and the resultant atherosclerosis in a mammal. The combinations are useful for reducing serum cholesterol, and/or cholesteryl ester, triglycerides, phospholipids and fatty acids in a mammal. The methods of the preferred embodiments comprise administering to a mammal a first amount of polychitosamine and a second amount of an HMG-CoA reductase inhibitor (statin). | 02-03-2011 |
Jocelyn Dupuis, Repentigny CA
| Patent application number | Description | Published |
|---|---|---|
| 20080274050 | Labelled Adrenomedullin Derivatives and Their Use for Imaging and Therapy - The present invention relates to an adrenomedullin derivative including an adrenomedullin peptide chelated with at least one active agent. Examples of active agents include a paramagnetic element, a radioactive element and a fibrinolytic agent, among others. Paramagnetic agents have a distribution that is relatively easily shown through Magnetic Resonance Imaging (MRI). Radioactive agents have applications in imaging and delivery of radiations, depending on the specific element included in the active agent. Delivery of fibrinolytic agents mainly to a specific organ, such us for example to the lungs, allows to substantially improve the specificity and efficacy of thrombolytic therapy by allowing local delivery of the fibrinolytic agent, thereby reducing the risks of major bleeding in the therapy of the organ. If the organ is the lungs, a non-limiting example of pathology treatable with the fibrinolytic is pulmonary embolus. | 11-06-2008 |
| 20090028790 | Labelled adrenomedullin derivatives and their use for imaging and therapy - The present invention relates to an adrenomedullin derivative including an adrenomedullin peptide, or a fragment thereof chelated or otherwise bound to at least one active agent. Examples of active agents include a paramagnetic element, a radioactive element and a fibrinolytic agent, among others. Paramagnetic agents have a distribution that is relatively easily shown through Magnetic Resonance Imaging (MRI). Radioactive agents have applications in imaging and delivery of radiations, depending on the specific element included in the active agent. Delivery of fibrinolytic agents mainly to a specific organ, such as for example to the lungs, allows to substantially improve the specificity and efficacy of thrombolytic therapy by allowing local delivery of the fibrinolytic agent, thereby reducing the risks of major bleeding in the therapy of the organ. If the organ is the lungs, a non-limiting example of pathology treatable with the fibrinolytic agent is pulmonary embolus. | 01-29-2009 |
Stephane Dupuis, Saint-Augustin-De-Desmaures CA
| Patent application number | Description | Published |
|---|---|---|
| 20090126747 | PLANT EXTRACTS AND USES THEREOF IN FILTER SYSTEMS - The present invention relates to compositions and methods for reducing the concentration of noxious substances in gases and smoke. Filters comprising plant extracts, such as parenchyma tissue extract and mesophyll cell extract, are also provided, as well as methods for making same. | 05-21-2009 |